These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35054279)

  • 21. Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort.
    Lawton M; Baig F; Toulson G; Morovat A; Evetts SG; Ben-Shlomo Y; Hu MT
    Mov Disord; 2020 Feb; 35(2):279-287. PubMed ID: 31693246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtypes of Parkinson's disease: state of the field and future directions.
    Marras C
    Curr Opin Neurol; 2015 Aug; 28(4):382-6. PubMed ID: 26110797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor subtype changes in early Parkinson's disease.
    Eisinger RS; Hess CW; Martinez-Ramirez D; Almeida L; Foote KD; Okun MS; Gunduz A
    Parkinsonism Relat Disord; 2017 Oct; 43():67-72. PubMed ID: 28754232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.
    Espay AJ; Schwarzschild MA; Tanner CM; Fernandez HH; Simon DK; Leverenz JB; Merola A; Chen-Plotkin A; Brundin P; Kauffman MA; Erro R; Kieburtz K; Woo D; Macklin EA; Standaert DG; Lang AE
    Mov Disord; 2017 Mar; 32(3):319-324. PubMed ID: 28233927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease: clinical features and diagnosis.
    Jankovic J
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):368-76. PubMed ID: 18344392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non motor subtypes and Parkinson's disease.
    Sauerbier A; Jenner P; Todorova A; Chaudhuri KR
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S41-6. PubMed ID: 26459660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A low-cost vision system based on the analysis of motor features for recognition and severity rating of Parkinson's Disease.
    Buongiorno D; Bortone I; Cascarano GD; Trotta GF; Brunetti A; Bevilacqua V
    BMC Med Inform Decis Mak; 2019 Dec; 19(Suppl 9):243. PubMed ID: 31830986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system.
    Liu SY; Chan P; Stoessl AJ
    Transl Neurodegener; 2017; 6():4. PubMed ID: 28239455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic architecture of Parkinson's disease subtypes - Review of the literature.
    Dulski J; Uitti RJ; Ross OA; Wszolek ZK
    Front Aging Neurosci; 2022; 14():1023574. PubMed ID: 36337703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
    Kang JH; Mollenhauer B; Coffey CS; Toledo JB; Weintraub D; Galasko DR; Irwin DJ; Van Deerlin V; Chen-Plotkin AS; Caspell-Garcia C; Waligórska T; Taylor P; Shah N; Pan S; Zero P; Frasier M; Marek K; Kieburtz K; Jennings D; Tanner CM; Simuni T; Singleton A; Toga AW; Chowdhury S; Trojanowski JQ; Shaw LM;
    Acta Neuropathol; 2016 Jun; 131(6):935-49. PubMed ID: 27021906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premotor biomarkers for Parkinson's disease - a promising direction of research.
    Haas BR; Stewart TH; Zhang J
    Transl Neurodegener; 2012 May; 1(1):11. PubMed ID: 23211054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Le W; Dong J; Li S; Korczyn AD
    Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical REM sleep behavior disorder and motor subtypes in Parkinson's disease: a questionnaire-based study.
    Aygun D; Turkel Y; Onar MK; Sunter T
    Clin Neurol Neurosurg; 2014 Apr; 119():54-8. PubMed ID: 24635926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease.
    Prell T; Witte OW; Grosskreutz J
    Front Neurol; 2019; 10():195. PubMed ID: 30906277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of motor subtype on non-motor symptoms and fall-related features in patients with early Parkinson's disease.
    Kwon KY; Lee EJ; Lee M; Ju H; Im K
    Geriatr Gerontol Int; 2021 May; 21(5):416-420. PubMed ID: 33780137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease.
    Zeighami Y; Fereshtehnejad SM; Dadar M; Collins DL; Postuma RB; Dagher A
    Neuroimage Clin; 2019; 24():101986. PubMed ID: 31514113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision medicine for Parkinson's disease: The subtyping challenge.
    Frasier M; Fiske BK; Sherer TB
    Front Aging Neurosci; 2022; 14():1064057. PubMed ID: 36533178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.